ANDERSON, DAVID R.,VOLKMANN, ROBERT A.,MENNITI, FRANK,FANGER, CHRISTOPHER,XU, YUELIAN
申请号：
CA3047403
公开号：
CA3047403A1
申请日:
2017.12.22
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
Disclosed herein, in part, are heteroaromatic compounds and methods of use in treating neuropsychiatric disorders, e.g., schizophrenia and major depressive disorder. Pharmaceutical compositions and methods of making heteroaromatic compounds are provided. The compounds are contemplated to modulate the NMDA receptor.
